关于药物联合心理干预对焦虑症失眠患者的疗效观察
2020-09-15房心翠李玉焕王立涛
房心翠 李玉焕 王立涛

【摘 要】 目的:对药物联合心理干预治疗焦虑症失眠患者的效果进行探究。方法:选择我院2018年10月—2019年10月收治的70例焦虑抑郁失眠患者,均分为对照组和试验组各35例,对照组只采用药物进行治疗,以此为基础对试验组患者辅助心理干预,对治疗前后两组患者的焦虑、抑郁、睡眠质量等进行比较。结果:治疗前两组患者焦虑、抑郁和睡眠质量评分无明显差异(P>0.05),治疗后试验组患者的焦虑、抑郁评分比对照组明显较低(P<0.05);且试验组患者的睡眠质量比对照组显著较低(P<0.05)。结论:采用药物联合心理干预对焦虑症失眠患者进行治疗可有效改善患者的焦虑、抑郁情情绪,使其睡眠质量提升,具有显著的临床疗效。
【关键词】 药物治疗;心理干预;虑症失眠患者;疗效
【中图分类号】 R197.6 【文献标志码】A 【文章编号】1005-0019(2020)17-018-01
Abstract:Objective:To explore the effect of drugs combined with psychological intervention on patients with anxiety and insomnia. Methods:A total of 70 patients with anxiety, depression, and insomnia treated in our hospital from October 2018 to October 2019 were selected and divided into a control group and a test group, each with 35 cases. The control group was treated with drugs only, and the test group was based on this Patient-assisted psychological intervention was used to compare anxiety, depression, and sleep quality between the two groups of patients before and after treatment. Results:There was no significant difference in anxiety, depression and sleep quality scores between the two groups of patients before treatment (P> 0.05). After treatment, the anxiety and depression scores of the test group were significantly lower than those of the control group (P <0.05). Sleep quality was significantly lower than that of the control group (P <0.05). Conclusion:Treatment of anxiety and insomnia patients with drugs and psychological intervention can effectively improve their anxiety and depression, improve their sleep quality, and have significant clinical effects.
Key words:medical treatement;Psychological intervention;Patients with anxiety and insomnia;Curative effect
随着近些年社会经济的快速发展和人们生活水平的较大提升,人们也越来越重视情绪状态,其中一种比较常见的心理障碍便是焦虑症,相关研究资料指出,当前焦虑症患病人群越来越趋向于年轻化。焦虑症指的是一种神经症,主要特征为持续性焦虑或反复发作的惊恐不安现象,患有焦虑症的患者会同时伴随易惊醒、做噩梦、入睡较难等睡眠障碍,睡眠质量较低会加重患者的焦虑情况,进而影响患者的社会功能和生活质量。本文分析了药物联合心理干预对焦虑症失眠患者的效果,具体报道为:
1 资料与方法
1.1 一般资料 选择我院2018年10月—2019年10月收治的70例焦虑抑郁失眠患者,按照其采用不同的治疗方法均分为对照组和试验组。对照组男女患者比例为23:12;年龄从23岁至60岁不等,均龄为(41.75±4.23)岁。试验组男女患者比例为22:13;年龄从22岁至59岁不等,均龄为(41.36±4.02)歲。比较……
